A randomised phase II study of modified FOLFIRI.3 vs modified FOLFOX as second-line therapy in patients with gemcitabine-refractory advanced pancreatic cancer

BACKGROUND: Only a few clinical trials have been conducted in patients with advanced pancreatic cancer after failure of first-line gemcitabine-based chemotherapy. Therefore, there is no current consensus on the treatment of these patients. We conducted a randomised phase II study of the modified FOL...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Yoo, C, Hwang, J Y, Kim, J-E, Kim, T W, Lee, J S, Park, D H, Lee, S S, Seo, D W, Lee, S K, Kim, M-H, Han, D J, Kim, S C, Lee, J-L
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2009
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2778540/
https://ncbi.nlm.nih.gov/pubmed/19826418
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6605374
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados